Skip to main content
. 2013 Jul 25;4:91. doi: 10.3389/fphar.2013.00091

Table 3.

Socio-economic factors affecting adherence.

Factors having
Negative effect on adherence Positive effect on adherence Neutral effect on adherence
FAMILY SUPPORT
  • Lack of family support (Nosé et al., 2003; Munro et al., 2007; Costello et al., 2008)

  • Irregular supervision by a family member (Munro et al., 2007P)

  • Child selfresponsibility for taking medication (Kahana et al., 2008)

  • Family financial support (Munro et al., 2007; Lanouette et al., 2009)

  • Family support in executing medication (Oehl et al., 2000; Munro et al., 2007; Lanouette et al., 2009)

  • Family emotional support (Weiner et al., 2008; Lanouette et al., 2009)

  • Family involvement during hospitalization or follow-up (Lacro et al., 2002)

FAMILY/CAREGIVERS FACTORS
  • Disorganized biologic families (Kahana et al., 2008; Karamanidou et al., 2008; Vreeman et al., 2008)

  • Family in conflict (Oehl et al., 2000; DiMatteo, 2004a; Vreeman et al., 2008; Weiner et al., 2008)

  • Responsibilities in the home (such as providing income and caring for children) (Munro et al., 2007)

  • Low parental educational level (Vreeman et al., 2008)

  • Family beliefs about the nature of the patient's illness (Julius et al., 2009)

  • More people in household (in children) (DiMatteo, 2004a)

  • Having several adults involved in pill supervision (Vreeman et al., 2008)

  • Two-parent families (Charach and Gajaria, 2008P)

  • Family cohesiveness (DiMatteo, 2004a)

  • Having an adult other than the biologic parent as primary caregiver (Reisner et al., 2009)

  • Higher caregiver education level (Reisner et al., 2009)

  • Responsibilities in the family (Munro et al., 2007)

  • Parental belief that ADHD is a biological condition (Charach and Gajaria, 2008P)

  • Mother's perception of the severity of disease (Hodari et al., 2006)

  • Knowledge of family members regarding disease (Lacro et al., 2002)

  • Family member with mental illness (Lanouette et al., 2009)

  • Number of people in the household (Vermeire et al., 2001)

  • Parental marital status (Charach and Gajaria, 2008P)

SOCIAL SUPPORT
  • Lack of social support (Oehl et al., 2000; Fogarty et al., 2002; DiMatteo, 2004a; Mills et al., 2006; Costello et al., 2008; Hirsch-Moverman et al., 2008; Karamanidou et al., 2008; Malta et al., 2008; Weiner et al., 2008; Julius et al., 2009; Schmid et al., 2009)

  • Less acculturation (Lanouette et al., 2009)

  • Low social functioning (Nosé et al., 2003)

  • Low social rank of an illness (Oehl et al., 2000)

  • Negative publicity regarding HAART or the medical establishment (Mills et al., 2006)

  • Emotional support (DiMatteo, 2004a)

  • Good social adjustment (Pampallona et al., 2002; Nosé et al., 2003)

  • Including significant others into therapeutic alliance (Oehl et al., 2000)

  • Supervision of medication administration by others (Weiner et al., 2008; Julius et al., 2009)

  • Patients' support to patients (Munro et al., 2007; Costello et al., 2008)

  • Social support (Reisner et al., 2009)

SOCIAL STIGMA OF A DISEASE
  • Stigma of a disease at school, at workplace, among the family and friends (Munro et al., 2007; Vreeman et al., 2008; Reisner et al., 2009)

  • Negative attitude in the patient's social surroundings toward psychiatric treatment (Oehl et al., 2000)

  • Fear of disclosure and wanting to avoid taking medications in public places (Mills et al., 2006)

  • Disclosure of the child's HIV status (Vreeman et al., 2008)

  • Hiding the disease (TB) for fear that employers may discover it (Munro et al., 2007)

  • Openly disclosing HIV status to family and friends (Mills et al., 2006)

COSTS OF DRUGS AND/OR TREATMENT
  • Cost of drugs (co-payment) (Vermeire et al., 2001; Gold et al., 2006P; Hodari et al., 2006; Lewiecki, 2007; Vreeman et al., 2008; Schmid et al., 2009)

  • Costs of drugs and treatment (Munro et al., 2007P; Costello et al., 2008P)

PRESCRIPTION COVERAGE
  • Lack of, or inadequate medical/prescription coverage (Charach and Gajaria, 2008P; Costello et al., 2008P; Lanouette et al., 2009; Schmid et al., 2009)

  • Fear of asking for money from employer to purchase drugs (in TB) (Munro et al., 2007)

  • Having health insurance (Lanouette et al., 2009)

SOCIOECONOMIC STATUS
  • Low income (Jindal et al., 2003; DiMatteo, 2004b; Munro et al., 2007; Schmid et al., 2009)

  • Poverty (Munro et al., 2007P; Costello et al., 2008P; Vreeman et al., 2008)

  • Lower socioeconomic status (DiMatteo, 2004b; Charach and Gajaria, 2008P; Lanouette et al., 2009)

  • Financial constraints (Oehl et al., 2000; Mills et al., 2006)

  • Wanting to remain sick to qualify for financial support (Munro et al., 2007)

  • Socioeconomic status (Vermeire et al., 2001; Munro et al., 2007; Charach and Gajaria, 2008P; Karamanidou et al., 2008; Weiner et al., 2008; Ruddy et al., 2009)

  • Financial support from outside the family (Lanouette et al., 2009)

EMPLOYMENT STATUS
  • Unemployment (Nosé et al., 2003; Hodari et al., 2006)

  • White-collar employment (Jindal et al., 2003)

  • Employment status (Karamanidou et al., 2008)

Abbreviations

TB

tuberculosis;

P

, determinant of persistence.